Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Vivimed Labs Limited per 2025 Jun 30 adalah 1,129.73 MM.
- Nilai operating income untuk Vivimed Labs Limited per 2025 Jun 30 adalah -188.70 MM.
- Nilai net income untuk Vivimed Labs Limited per 2025 Jun 30 adalah -222.09 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 1,129.73 | -188.70 | -222.09 |
2025-03-31 | 1,206.40 | -289.01 | -319.61 |
2024-12-31 | 1,370.50 | -444.22 | -210.99 |
2024-06-30 | 1,530.17 | -460.12 | -451.16 |
2024-03-31 | 1,590.47 | -359.78 | -454.46 |
2023-12-31 | 1,505.19 | -1,865.42 | -3,166.95 |
2023-09-30 | 1,648.10 | -1,922.46 | -3,189.58 |
2023-06-30 | 1,733.44 | -2,867.19 | -3,219.04 |
2023-03-31 | 1,880.67 | -2,050.50 | -3,285.36 |
2022-12-31 | 2,120.57 | -406.77 | -808.79 |
2022-09-30 | 2,124.26 | -436.83 | -862.50 |
2022-06-30 | 2,225.69 | -451.85 | -875.19 |
2022-03-31 | 2,385.57 | -250.73 | -676.50 |
2021-12-31 | 2,176.29 | -383.08 | -767.81 |
2021-09-30 | 4,437.54 | -602.40 | -1,026.47 |
2021-06-30 | 6,128.73 | -458.17 | -929.67 |
2021-03-31 | 8,712.90 | -68.52 | -718.86 |
2020-12-31 | 10,687.58 | -357.33 | -1,111.70 |
2020-09-30 | 9,862.62 | -272.74 | -936.93 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -2.54 | -2.54 |
2024-06-30 | -5.44 | -5.44 |
2024-03-31 | -5.48 | |
2023-12-31 | -38.23 | -38.23 |
2023-09-30 | -38.49 | -38.49 |
2023-06-30 | -38.82 | -38.82 |
2023-03-31 | -39.62 | |
2022-12-31 | ||
2022-09-30 | -10.40 | -10.40 |
2022-06-30 | -10.57 | -10.57 |
2022-03-31 | -8.16 | |
2021-12-31 | -9.26 | -9.26 |
2021-09-30 | -12.68 | -12.68 |
2021-06-30 | -11.19 | -11.19 |
2021-03-31 | -8.67 | |
2020-12-31 | -13.41 | -13.41 |
2020-09-30 | -11.05 | -11.05 |
2020-06-30 | -12.85 | -12.85 |
2020-03-31 | -13.16 |
Arus Kas: Operasi, Investasi, Pendanaan
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | -17.51 | -45.31 | 49.64 |
2024-12-31 | |||
2024-06-30 | |||
2024-03-31 | -239.91 | 282.88 | -60.32 |
2023-12-31 | |||
2023-09-30 | 2,005.06 | -958.86 | -1,610.01 |
2023-06-30 | |||
2023-03-31 | 353.22 | -49.68 | -337.82 |
2022-12-31 | |||
2022-09-30 | -6,732.26 | 5,433.21 | -167.08 |
2022-06-30 | |||
2022-03-31 | 275.40 | -164.10 | -103.79 |
2021-12-31 | |||
2021-09-30 | 5,095.02 | 4,678.44 | -10,187.43 |
2021-06-30 | |||
2021-03-31 | 5,672.75 | 4,040.01 | -10,153.32 |
2020-12-31 | |||
2020-09-30 | 1,257.32 | -2,963.22 | 1,219.13 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -1.26.
- p/libro untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -1.15.
- p/tbv untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -0.21.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -1.26 | -1.15 | -0.21 |
2025-03-31 | -1.93 | ||
2024-12-31 | -1.93 | ||
2024-06-30 | -0.13 | 0.23 | 0.23 |
2024-03-31 | -0.13 | 0.23 | -0.54 |
2023-12-31 | -0.13 | 0.23 | -0.54 |
2023-09-30 | -0.13 | 1.03 | -0.34 |
2023-06-30 | -0.13 | 1.03 | -0.34 |
2023-03-31 | -0.12 | 1.03 | -0.34 |
2022-12-31 | -0.47 | 0.13 | 0.25 |
2022-09-30 | -0.95 | 0.23 | 0.40 |
2022-06-30 | -0.77 | 0.19 | 0.33 |
2022-03-31 | -1.00 | 0.19 | 0.33 |
2021-12-31 | -0.88 | 0.17 | 0.27 |
2021-09-30 | -0.66 | 0.17 | 0.29 |
2021-06-30 | -0.73 | 0.16 | 0.26 |
2021-03-31 | -0.87 | 0.16 | 0.26 |
2020-12-31 | -0.61 | 0.08 | 0.14 |
2020-09-30 | -0.72 | 0.08 | 0.26 |
2020-06-30 | -0.64 | 0.08 | 0.25 |
2020-03-31 | -0.62 | 0.08 | 0.25 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -0.08.
- EBIT (3 tahun) / EV untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -0.32.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.08 | -0.32 |
2025-03-31 | -0.49 | -3.43 |
2024-12-31 | 0.00 | -3.27 |
2024-06-30 | -7.89 | -5.87 |
2024-03-31 | -0.90 | -0.44 |
2023-12-31 | -0.90 | -0.47 |
2023-09-30 | -0.78 | -0.40 |
2023-06-30 | -0.78 | -0.40 |
2023-03-31 | -0.46 | -0.22 |
2022-12-31 | -0.21 | -0.23 |
2022-09-30 | -0.24 | -0.26 |
2022-06-30 | -0.20 | -0.22 |
2022-03-31 | -0.15 | -0.19 |
2021-12-31 | -0.18 | -0.19 |
2021-09-30 | -0.24 | -0.16 |
2021-06-30 | -0.13 | -0.07 |
2021-03-31 | -0.10 | -0.05 |
2020-12-31 | -0.08 | -0.02 |
2020-09-30 | -0.06 | -0.00 |
2020-06-30 | -0.08 | 0.01 |
2020-03-31 | -0.08 | 0.01 |
Efektivitas Manajemen
- roa untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -0.03.
- roic untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -0.09.
- croic untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -0.00.
- ocroic untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -0.01.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.03 | -0.09 | -0.00 | -0.01 | |
2025-03-31 | -0.02 | -0.12 | |||
2024-12-31 | 0.00 | -0.12 | |||
2024-06-30 | -0.32 | -1.15 | -1.79 | 0.00 | 1.13 |
2024-03-31 | -0.25 | -0.99 | -0.64 | 0.00 | 0.40 |
2023-12-31 | -0.26 | -1.00 | -0.64 | 0.00 | 0.40 |
2023-09-30 | -0.25 | -0.88 | -0.77 | 0.00 | 0.00 |
2023-06-30 | -0.25 | -0.88 | -0.77 | -0.01 | 0.03 |
2023-03-31 | -0.26 | -0.90 | -0.45 | -0.00 | 0.02 |
2022-12-31 | -0.07 | -0.21 | -0.13 | -0.00 | 0.02 |
2022-09-30 | -0.07 | -0.22 | -0.14 | -0.00 | 0.02 |
2022-06-30 | -0.07 | -0.20 | -0.12 | -0.20 | -0.90 |
2022-03-31 | -0.05 | -0.16 | -0.09 | -0.20 | -0.90 |
2021-12-31 | -0.03 | -0.09 | -0.10 | -0.05 | 0.67 |
2021-09-30 | -0.04 | -0.12 | -0.13 | -0.05 | 0.67 |
2021-06-30 | -0.04 | -0.11 | -0.12 | -0.06 | 0.73 |
2021-03-31 | -0.04 | -0.09 | -0.10 | -0.06 | 0.73 |
2020-12-31 | -0.05 | -0.12 | -0.06 | -0.03 | 0.07 |
2020-09-30 | -0.04 | -0.10 | -0.05 | -0.03 | 0.07 |
2020-06-30 | -0.05 | -0.11 | -0.06 | -0.02 | 0.04 |
2020-03-31 | -0.05 | -0.12 | -0.06 | -0.02 | 0.04 |
Gross Margins
- marjin kotor untuk Vivimed Labs Limited pada 2025 Jun 30 adalah 0.50.
- marjin bersih untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -0.26.
- marjin operasi untuk Vivimed Labs Limited pada 2025 Jun 30 adalah -0.24.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.50 | -0.26 | -0.24 |
2025-03-31 | 0.54 | -0.15 | -0.32 |
2024-12-31 | 0.54 | -0.15 | -0.32 |
2024-06-30 | -0.61 | -2.10 | -1.24 |
2024-03-31 | -0.61 | -2.10 | -1.24 |
2023-12-31 | -0.57 | -1.94 | -1.17 |
2023-09-30 | -0.51 | -1.86 | -1.14 |
2023-06-30 | -0.51 | -1.86 | -1.65 |
2023-03-31 | -0.44 | -1.75 | -1.57 |
2022-12-31 | 0.38 | -0.41 | -0.21 |
2022-09-30 | 0.38 | -0.41 | -0.21 |
2022-06-30 | 0.33 | -0.39 | -0.20 |
2022-03-31 | 0.36 | -0.28 | -0.11 |
2021-12-31 | 0.28 | -0.35 | -0.11 |
2021-09-30 | 0.53 | -0.23 | -0.14 |
2021-06-30 | 0.58 | -0.15 | -0.07 |
2021-03-31 | 0.59 | -0.09 | -0.03 |
2020-12-31 | 0.58 | -0.10 | -0.03 |
2020-09-30 | 0.59 | -0.09 | -0.02 |
2020-06-30 | 0.56 | -0.10 | -0.04 |
2020-03-31 | 0.57 | -0.10 | -0.05 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |